Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

about

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus

P2860

Q57170242-C20C8B0D-5865-4EAF-8503-09C1D3D2BB10

P2860

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

Item

http://www.wikidata.org/entity/Q47097470

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@en

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@nl

type

Item

label

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@en

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@nl

prefLabel

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@en

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@nl

P1476

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

@en

P2093

Ashley Ansel

http://www.w3.org/2001/XMLSchema#string

Beni Gesundheit

http://www.w3.org/2001/XMLSchema#string

Joshua P Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Philip D Zisman

http://www.w3.org/2001/XMLSchema#string

P2860

Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates.

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

History of oncolytic viruses: genesis to genetic engineering.

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

Gene therapy progress and prospects cancer: oncolytic viruses.

First oncolytic virus approved for melanoma immunotherapy.

Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer

Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.

Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.

Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61

P304

264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2017.00264

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29164063

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5681714

http://www.w3.org/2001/XMLSchema#string

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

about

P2860

P2860

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932